 |
3-(3,5-dimethyl-1H-2ylmethylene)-1,3-dihydro-indol-2-one |
|---|---|
| Trade Name | |
| Orphan Indication | Kaposi sarcoma |
| USA Market Approval | USA |
| USA Designation Date | 1998-09-11 00:00:00 |
| Sponsor | Sugen, Inc.;230 East Grand Ave.;South San Francisco, California, 94080 |
| |
3-(3,5-dimethyl-1H-2ylmethylene)-1,3-dihydro-indol-2-one |
|---|---|
| Trade Name | |
| Orphan Indication | Kaposi sarcoma |
| USA Market Approval | USA |
| USA Designation Date | 1998-09-11 00:00:00 |
| Sponsor | Sugen, Inc.;230 East Grand Ave.;South San Francisco, California, 94080 |